{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:15:42Z","timestamp":1762521342207},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.gastrohep.2010.01.010","type":"journal-article","created":{"date-parts":[[2010,4,6]],"date-time":"2010-04-06T20:13:36Z","timestamp":1270584816000},"page":"377-381","source":"Crossref","is-referenced-by-count":3,"title":["Reactivaci\u00f3n de la hepatitis B en un paciente HBsAg negativo\/antiHBc positivo con linfoma B que recibi\u00f3 quimioterapia con rituximab"],"prefix":"10.1016","volume":"33","author":[{"given":"Eduardo","family":"Mu\u00f1oz Bertr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"P\u00e9rez Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"G\u00f3mez Esp\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ortega Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2010.01.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: Update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cgh.2006.05.027","article-title":"Hepatitis B virus reactivation after cytotoxic chemotherapy: The disease and its prevention","volume":"4","author":"Mindikoglu","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cld.2007.08.006","article-title":"Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection","volume":"11","author":"Kohrt","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib8","first-page":"2925","article-title":"Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients","volume":"46","author":"Markovic","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.1999.17.1.394","article-title":"Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem","volume":"17","author":"Liang","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2010.01.010_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/8.suppl_1.S107","article-title":"Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan","volume":"8","author":"Kumagai","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2002.03239.x","article-title":"Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma","volume":"116","author":"Liao","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib12","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2003.09.026","article-title":"Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy","volume":"125","author":"Lau","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib14","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol. 2009;50:227\u201342","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2003.50171","article-title":"Long-term histologic and virologic outcomes of acute self-limited hepatitis B","volume":"37","author":"Yuki","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0609.2001.067001045.x","article-title":"Incidence of hepatitis virus infection and severe liver dysfuncion in patients receiving chemotherapy for hematologic malignancies","volume":"67","author":"Kawatani","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/gast.2001.22461","article-title":"Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease","volume":"120","author":"Perrillo","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/vir.0.18678-0","article-title":"Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent","volume":"84","author":"Lazdina","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/1042819031000151923","article-title":"Hepatitis B virus reactivation in a case of non-Hodgkin\u2032s lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy","volume":"45","author":"Tsutsumi","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-004-0948-6","article-title":"Hepatitis B reactivation in a patient receiving radiolabeled rituximab","volume":"84","author":"Soong","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00001813-200501000-00012","article-title":"Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab","volume":"16","author":"Zell","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib23","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood-2003-05-1403","article-title":"Fatal hepatitis virus reactivation by an scape mutant following rituximab therapy","volume":"102","author":"Westhoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/10428190500062932","article-title":"Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations","volume":"46","author":"Law","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib25","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.leu.2403914","article-title":"Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy","volume":"19","author":"Niscola","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2169\/internalmedicine.45.1590","article-title":"Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab","volume":"45","author":"Sera","year":"2006","journal-title":"Inter Med"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10156-005-0385-Z","article-title":"HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb","volume":"11","author":"Sarrecchia","year":"2005","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10428190601059704","article-title":"Fulminant B hepatitis in a surface antigen and hepatitis B ADN-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab","volume":"48","author":"Yamagata","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/590968","article-title":"Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan","volume":"47","author":"Umemura","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cgh.2006.05.016","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update","volume":"4","author":"Keeffe","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2010.01.010_bib33","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/cncr.21701","article-title":"Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570510000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570510000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T20:51:03Z","timestamp":1558990263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570510000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0210570510000452"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2010.01.010","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}